{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:35:30Z","timestamp":1783632930718,"version":"3.55.0"},"reference-count":37,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AIR Lund","award":["2019-61406"],"award-info":[{"award-number":["2019-61406"]}]},{"name":"Lund University Infrastructure Grants","award":["STYR 2019\/2046"],"award-info":[{"award-number":["STYR 2019\/2046"]}]},{"name":"Lund University Infrastructure Grants","award":["2019\/318"],"award-info":[{"award-number":["2019\/318"]}]},{"name":"European Research Council AdG","award":["2019-885003"],"award-info":[{"award-number":["2019-885003"]}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF200C0063465"],"award-info":[{"award-number":["NNF200C0063465"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2023-01989"],"award-info":[{"award-number":["2023-01989"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Heart and Lung Foundation","award":["20210253"],"award-info":[{"award-number":["20210253"]}]},{"name":"Ernhold Lundstrom Research Foundation, Hulda and E Conrad Mossfelts Foundation"},{"name":"Albert Pahlsson Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Peptidylglycine-\u03b1-amidating monooxygenase (PAM) is a critical enzyme in the endocrine system responsible for activation, by amidation, of bioactive peptides.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To define the clinical phenotype of carriers of genetic mutations associated with impaired PAM-amidating activity (PAM-AMA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>We used genetic and phenotypic data from cohort studies: the Malm\u00f6 Diet and Cancer (MDC; 1991-1996; reexamination in 2002-2012), the Malm\u00f6 Preventive Project (MPP; 2002-2006), and the UK Biobank (UKB; 2012).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Exome-wide association analysis was used to identify loss-of-function (LoF) variants associated with reduced PAM-AMA and subsequently used for association with the outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients or Other Participants<\/jats:title>\n                  <jats:p>This study included n\u223c4500 participants from a subcohort of the MDC (MDC-Cardiovascular cohort), n\u223c4500 from MPP, and n\u223c300,000 from UKB.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Endocrine-metabolic traits suggested by prior literature, muscle mass, muscle function, and sarcopenia.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Two LoF variants in the PAM gene, Ser539Trp (minor allele frequency: 0.7%) and Asp563Gly (5%), independently contributed to a decrease of 2.33 [95% confidence interval (CI): 2.52\/2.15; P = 2.5E\u2212140] and 0.98 (1.04\/0.92; P = 1.12E\u2212225) SD units of PAM-AMA, respectively. The cumulative effect of the LoF was associated with diabetes, reduced insulin secretion, and higher levels of GH and IGF-1. Moreover, carriers had reduced muscle mass and function, followed by a higher risk of sarcopenia. Indeed, the Ser539Trp mutation increased the risk of sarcopenia by 30% (odds ratio 1.31; 95% CI: 1.16\/1.47; P = 9.8E\u221206), independently of age and diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>PAM-AMA genetic deficiency results in a prediabetic sarcopenic phenotype. Early identification of PAM LoF carriers would allow targeted exercise interventions and calls for novel therapies that restore enzymatic activity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae510","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T18:29:03Z","timestamp":1723573743000},"page":"820-829","source":"Crossref","is-referenced-by-count":13,"title":["Deficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes Mellitus"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7242-437X","authenticated-orcid":false,"given":"Alice","family":"Giontella","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , 205 02 Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Clinical Sciences Malm\u00f6, Lund University Diabetes Center, Lund University , 205 02 Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"\u00c5kerlund","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , 205 02 Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Clinical Sciences Malm\u00f6, Lund University Diabetes Center, Lund University , 205 02 Malm\u00f6 ,","place":["Sweden"]},{"name":"Clinical Research Center, Sk\u00e5ne University Hospital , 205 02 Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Bronton","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , 205 02 Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Emergency and Internal Medicine, Sk\u00e5ne University Hospital , 205 02 Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8910-7378","authenticated-orcid":false,"given":"Cristiano","family":"Fava","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , 205 02 Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Medicine, University of Verona , 37134 Verona ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca A","family":"Lotta","sequence":"additional","affiliation":[{"name":"Regeneron Genetics Center, Regeneron Pharmaceuticals , Tarrytown, NY 10591 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6830-3396","authenticated-orcid":false,"given":"Aris","family":"Baras","sequence":"additional","affiliation":[{"name":"Regeneron Genetics Center, Regeneron Pharmaceuticals , Tarrytown, NY 10591 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Overton","sequence":"additional","affiliation":[{"name":"Regeneron Genetics Center, Regeneron Pharmaceuticals , Tarrytown, NY 10591 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Jones","sequence":"additional","affiliation":[{"name":"Regeneron Genetics Center, Regeneron Pharmaceuticals , Tarrytown, NY 10591 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bergmann","sequence":"additional","affiliation":[{"name":"PAM Theragnostics GmbH , 16761 Hennigsdorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kaufmann","sequence":"additional","affiliation":[{"name":"PAM Theragnostics GmbH , 16761 Hennigsdorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Ilina","sequence":"additional","affiliation":[{"name":"PAM Theragnostics GmbH , 16761 Hennigsdorf ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2581-484X","authenticated-orcid":false,"given":"Olle","family":"Melander","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences Malm\u00f6, Lund University , 205 02 Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Clinical Sciences Malm\u00f6, Lund University Diabetes Center, Lund University , 205 02 Malm\u00f6 ,","place":["Sweden"]},{"name":"Clinical Research Center, Sk\u00e5ne University Hospital , 205 02 Malm\u00f6 ,","place":["Sweden"]},{"name":"Department of Emergency and Internal Medicine, Sk\u00e5ne University Hospital , 205 02 Malm\u00f6 ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"1","key":"2025021815520118900_dgae510-B1","doi-asserted-by":"crossref","first-page":"15791","DOI":"10.1038\/s41598-021-95305-y","article-title":"Novel insights into peptide amidation and amidating activity in the human circulation","volume":"11","author":"Kaufmann","year":"2021","journal-title":"Sci Rep"},{"issue":"5341","key":"2025021815520118900_dgae510-B2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.278.5341.1300","article-title":"Amidation of bioactive peptides: the structure of peptidylglycine \u03b1-hydroxylating monooxygenase","volume":"278","author":"Prigge","year":"1997","journal-title":"Science"},{"issue":"8","key":"2025021815520118900_dgae510-B3","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s41588-018-0173-1","article-title":"Type 2 diabetes risk alleles in PAM impact insulin release from human pancreatic \u03b2-cells","volume":"50","author":"Thomsen","year":"2018","journal-title":"Nat Genet"},{"issue":"30","key":"2025021815520118900_dgae510-B4","doi-asserted-by":"crossref","first-page":"17820","DOI":"10.1073\/pnas.2004410117","article-title":"Peptidylglycine \u03b1-amidating monooxygenase is required for atrial secretory granule formation","volume":"117","author":"B\u00e4ck","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2025021815520118900_dgae510-B5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10142-022-00840-0","article-title":"PAM variants were associated with type 2 diabetes mellitus risk in the Chinese population","volume":"22","author":"Sheng","year":"2022","journal-title":"Funct Integr Genomics"},{"issue":"3","key":"2025021815520118900_dgae510-B6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00125-019-05060-z","article-title":"PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice","volume":"63","author":"Chen","year":"2020","journal-title":"Diabetologia"},{"key":"2025021815520118900_dgae510-B7","doi-asserted-by":"crossref","first-page":"1305606","DOI":"10.3389\/fendo.2023.1305606","article-title":"PAM variants in patients with thyrotrophinomas, cyclical Cushing's disease and prolactinomas","volume":"14","author":"De Sousa","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025021815520118900_dgae510-B8","doi-asserted-by":"crossref","first-page":"1166076","DOI":"10.3389\/fendo.2023.1166076","article-title":"Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion","volume":"14","author":"Trivellin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025021815520118900_dgae510-B9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2796.1993.tb00647.x","article-title":"The malmo diet and cancer study. Design and feasibility","volume":"233","author":"Berglund","year":"1993","journal-title":"J Intern Med"},{"issue":"4","key":"2025021815520118900_dgae510-B10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1464-5491.2000.00280.x","article-title":"Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in malm\u00f6, Sweden","volume":"17","author":"Hedblad","year":"2000","journal-title":"Diabet Med"},{"issue":"6","key":"2025021815520118900_dgae510-B11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1365-2796.1996.483819000.x","article-title":"Cardiovascular risk groups and mortality in an urban Swedish male population: the malm\u00f6 preventive project","volume":"239","author":"Berglund","year":"1996","journal-title":"J Int Med"},{"issue":"7886","key":"2025021815520118900_dgae510-B12","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41586-021-04103-z","article-title":"Exome sequencing and analysis of 454,787 UK biobank participants","volume":"599","author":"Backman","year":"2021","journal-title":"Nature"},{"key":"2025021815520118900_dgae510-B13","doi-asserted-by":"crossref","unstructured":"Giontella A, \u00c5kerlund M, Bronton K, et al \u00a0Supplementary data for \u201cDeficiency of Peptidylglycine-alpha-amidating Monooxygenase, a Cause of Sarcopenic Diabetes Mellitus\u201d. Zenodo. 2024. https:\/\/zenodo.org\/doi\/10.5281\/zenodo.13144414","DOI":"10.1210\/clinem\/dgae510"},{"issue":"7","key":"2025021815520118900_dgae510-B14","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","article-title":"Computationally efficient whole-genome regression for quantitative and binary traits","volume":"53","author":"Mbatchou","year":"2021","journal-title":"Nat Genet"},{"issue":"2","key":"2025021815520118900_dgae510-B15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/dc19-1199","article-title":"Plasma lipidome and prediction of type 2 diabetes in the population-based malm\u00f6 diet and cancer cohort","volume":"43","author":"Fernandez","year":"2019","journal-title":"Diabetes Care"},{"issue":"7","key":"2025021815520118900_dgae510-B16","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/dme.14267","article-title":"Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population-based study","volume":"37","author":"Dybjer","year":"2020","journal-title":"Diabet Med"},{"issue":"14","key":"2025021815520118900_dgae510-B17","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jacc.2014.03.063","article-title":"Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality","volume":"64","author":"Hallengren","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"2025021815520118900_dgae510-B18","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/1354750X.2019.1631886","article-title":"B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD","volume":"24","author":"Fatemi","year":"2019","journal-title":"Biomarkers"},{"issue":"1","key":"2025021815520118900_dgae510-B19","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/s41467-020-15948-9","article-title":"The UK biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions","volume":"11","author":"Littlejohns","year":"2020","journal-title":"Nat Commun"},{"key":"2025021815520118900_dgae510-B20","author":"Dayimu"},{"issue":"9","key":"2025021815520118900_dgae510-B21","doi-asserted-by":"crossref","first-page":"102835","DOI":"10.1016\/j.dsx.2023.102835","article-title":"Sarcopenia and type 2 diabetes: pathophysiology and potential therapeutic lifestyle interventions","volume":"17","author":"Marcotte-Ch\u00e9nard","year":"2023","journal-title":"Diabetes Metab Syndr"},{"issue":"11","key":"2025021815520118900_dgae510-B22","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","article-title":"Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet"},{"issue":"7759","key":"2025021815520118900_dgae510-B23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-019-1231-2","article-title":"Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls","volume":"570","author":"Flannick","year":"2019","journal-title":"Nature"},{"issue":"1","key":"2025021815520118900_dgae510-B24","doi-asserted-by":"crossref","first-page":"21565","DOI":"10.1038\/s41598-021-99091-5","article-title":"Gene-level analysis of rare variants in 379,066 whole exome sequences identifies an association of GIGYF1 loss of function with type 2 diabetes","volume":"11","author":"Deaton","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"2025021815520118900_dgae510-B25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng.2507","article-title":"Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion","volume":"45","author":"Huyghe","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"2025021815520118900_dgae510-B26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41574-020-0325-0","article-title":"Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics","volume":"16","author":"Krentz","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"2025021815520118900_dgae510-B27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metabol"},{"issue":"5","key":"2025021815520118900_dgae510-B28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0306-3623(98)00192-X","article-title":"Peptidylglycine \u03b1-amidating mono-oxygenase: neuropeptide amidation as a target for drug design","volume":"31","author":"Bolkenius","year":"1998","journal-title":"Gen Pharmacol"},{"issue":"1","key":"2025021815520118900_dgae510-B29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1900\/RDS.2020.16.24","article-title":"Insulin-like growth factor and its therapeutic potential for diabetes complications\u2014mechanisms and metabolic links: a review","volume":"16","author":"Biadgo","year":"2021","journal-title":"Rev Diabet Stud"},{"issue":"1","key":"2025021815520118900_dgae510-B30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11154-020-09594-1","article-title":"Current concepts of the diagnosis of adult growth hormone deficiency","volume":"22","author":"Tritos","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"2025021815520118900_dgae510-B31","doi-asserted-by":"crossref","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","article-title":"Epidemiology of sarcopenia: prevalence, risk factors, and consequences","volume":"144","author":"Yuan","year":"2023","journal-title":"Metab Clin Exp"},{"key":"2025021815520118900_dgae510-B32","doi-asserted-by":"crossref","first-page":"971622","DOI":"10.3389\/fmed.2022.971622","article-title":"Lower insulin level is associated with sarcopenia in community-dwelling frail and non-frail older adults","volume":"9","author":"Lu","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"Suppl 1","key":"2025021815520118900_dgae510-B33","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.2337\/dc23-S010","article-title":"10. cardiovascular disease and risk management: standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"7138","key":"2025021815520118900_dgae510-B34","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/bmj.316.7138.1132","article-title":"Growth hormone as a risk for premature mortality in healthy subjects: data from the Paris prospective study","volume":"316","author":"Maison","year":"1998","journal-title":"BMJ"},{"issue":"1","key":"2025021815520118900_dgae510-B35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"2025021815520118900_dgae510-B36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2147\/CIA.S366245","article-title":"High intensity interval training: a potential method for treating sarcopenia","volume":"17","author":"Liu","year":"2022","journal-title":"Clin Interv Aging"},{"issue":"12","key":"2025021815520118900_dgae510-B37","first-page":"CD003054","article-title":"Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus","volume":"2017","author":"Hemmingsen","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae510\/58812427\/dgae510.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/3\/820\/58812427\/dgae510.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/3\/820\/58812427\/dgae510.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:16:56Z","timestamp":1739895416000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/3\/820\/7732930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,8,13]]},"published-print":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae510","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,8,13]]}}}